| http://www.w3.org/ns/prov#value | - The present invention relates to the use of the compounds of formula I to treat diseases and conditions treated by muscarinic receptor modulators, for example, Alzheimer's disease, glaucoma, mania, bipolar disorder, depression, sleeping disorders, epilepsy, gastrointestinal motility disorders, urinary incontinence, pain, psychosis, particularly schizophrenia or schizophreniform conditions, and cog
|
